 |
|
Top notch decisions in the developing airways bring insights into lung disease
June 09, 2009(Boston) - In the normal lung, the airways are lined by a balanced mixture of ciliated, secretory and neuroendocrine cells which perform functions as diverse as air humidification, detoxification, and clearance of environmental particles. This balance can be altered dramatically by faulty adaptation responses of the lung to cigarette smoke or allergens in patients with Chronic Obstructive Pulmonary Disease (COPD) and asthma.
How these different cell types emerge from lung progenitor cells and how these fates are balanced in developing airways, remain an open question. A study from a research team led by Wellington Cardoso, MD, a professor at the Pulmonary Center Boston University School of Medicine and Director of the Program in Lung Development and Progenitor Cell Biology, sheds light into this problem.
The Notch pathway is a major regulator of cell fate decisions in developing cells from fruit flies to humans. Using mouse genetic models, the BU researchers inactivated Notch signaling in the lung and discovered that airways no longer formed secretory cells. Instead they became populated almost exclusively by ciliated cells. The researchers showed that this imbalance seems to result from the loss of a mechanism of cell fate choice triggered by the Notch called lateral inhibition.
"When you lose Notch signaling, you lose the ability to generate secretory cells that make the lining fluid critical for protection and integrity of airway, and the other fate, of ciliated cells is de-repressed" said Dr. Cardoso.
These findings help to understand how airways form and provide insights into how interfering with Notch signaling may be potentially useful as a therapeutic intervention in respiratory diseases, such as asthma and COPD, in which airways have an overabundance of secretory cells and paucity of ciliated cells in the airways. The link between hyperactive Notch and excessive secretion is now rapidly emerging from other recent reports.
Boston University Medical Center
"When you lose Notch signaling, you lose the ability to generate secretory cells that make the lining fluid critical for protection and integrity of airway, and the other fate, of ciliated cells is de-repressed" said Dr. Cardoso.
These findings help to understand how airways form and provide insights into how interfering with Notch signaling may be potentially useful as a therapeutic intervention in respiratory diseases, such as asthma and COPD, in which airways have an overabundance of secretory cells and paucity of ciliated cells in the airways. The link between hyperactive Notch and excessive secretion is now rapidly emerging from other recent reports.
Boston University Medical Center
Lung Disease Current Events and Lung Disease News RSSSurvey: Awareness of COPD is rising, but understanding is still low
Awareness of COPD-chronic obstructive pulmonary disease-continues to grow in the United States, according to national survey results released today by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.
Multicenter study led by pitt finds early results of therapy for preemies not sustained
Inhaled nitric oxide (iNO), a therapy used in the treatment of premature newborns with respiratory failure that had shown promising results in short-term studies, does not significantly improve long-term outcomes, according to a national study led by critical care researchers at the University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh of UPMC.
Geneticists Hunt for Scleroderma Triggers
At its most benign, the autoimmune disease scleroderma can discolor parts of the skin of its sufferers. At its most pernicious, it can thicken and harden their skin, their blood vessels, and their internal organs before, in many cases, killing them.
Thyroid surgery safe for older patients, study finds
Thyroid surgery is safe for older patients, say physicians who found only slight differences in rates of complications and hospital readmissions in a multi-year study.
Drug could provide first treatment for scleroderma
Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease for which a treatment has remained elusive.
People who work after retiring enjoy better health, according to national study
Retirees who transition from full-time work into a temporary or part-time job experience fewer major diseases and are able to function better day-to-day than people who stop working altogether, according to a national study.
UT scientists discover link between protein and lung disease
In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD).
UAB Researchers Find TB-Prevention Therapy Is Cost-Effective Option
University of Alabama at Birmingham (UAB) researchers have found that the cost of preventive antibiotic tuberculosis (TB) therapy for patients infected by human immunodeficiency virus (HIV) is generally less expensive than the reported cost of treating newly confirmed TB cases.
New vaccine shows promise for COPD patients at risk for pneumonia
A new vaccine against pneumonia may offer better protection from chronic obstructive pulmonary disease (COPD) patients than the currently accepted vaccine, according to recent research that will be published in the September 15 issue of the American Journal of the Respiratory and Critical Care Journal, a publication of the American Thoracic Society.
New genes at work in patients with hereditary lung disease
University of Florida researchers have safely given new, functional genes to patients with a hereditary defect that can lead to fatal lung and liver diseases, according to clinical trial findings slated to appear this week in the online early edition of the Proceedings of the National Academy of Sciences.
More Lung Disease Current Events and Lung Disease News Articles
 |
Pulmonary Arterial Hypertension and Interstitial Lung Diseases: A Clinical Guide by Robert P. Baughman (Editor), Roberto G. Carbone (Editor), Giovanni Bottino (Editor) Interstitial lung disease (ILD) is a broad category of lung diseases that includes more than 150 disorders characterized by scarring or fibrosis of the lungs. In Pulmonary Arterial Hypertension and Interstitial Lung Disease: A Clinical Guide, renowned experts provide a state-of-the-art overview of the problems seen by physicians in the clinical management of ILDs. Divided into two sections, the first part provides and update on general issues and introduces both interstitial lung disease and associated pulmonary hypertension. A detailed analysis of the pathology of the various interstitial lung diseases is also provided. The second part addresses specific categories of disease. Bronchiolitis, hypersensitivity pneumonitis, and other conditions are covered, and the use of inspiratory and... |
 |
Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Lung Biology in Health and Disease) by Nikos Siafakas (Editor), Nicholas R. Anthonisen (Editor), Dimitris Georgopoulos (Editor) Aids practitioners who are looking to more effectively diagnose, treat, and manage patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Discusses pulmonary gas exchange, muscle function and breathing, water/electrolyte imbalances, and end stage disease in AECOPD. |
 |
Fishman's Pulmonary Diseases and Disorders (2-Volume Set) by Alfred Fishman (Author), Jack Elias (Author), Jay Fishman (Author), Michael Grippi (Author), Robert Senior (Author), Allan Pack (Author) A complete guide to the entire field of respiratory medicine--with all-new content and a streamlined new design First published in 1980, Fishman's Pulmonary Diseases and Disorders is the classic reference through which pulmonary physicians have gained a commanding look at the diagnosis and treatment of pulmonary diseases and disorders. Edited by the world's foremost authorities, Fishman's Pulmonary Diseases and Disorders covers exactly what you need to know about lung diseases and their management, including sleep-disordered breathing, COPD, emphysema, and lung cancer, as well as new technological advances and imaging techniques. This unparalleled two-volume resource begins with a compelling overview of up-to-date clinical perspectives, along with the... |
 |
Pulmonary Hypertension (Lung Biology in Health and Disease) by Marc Humbert (Editor), Joseph P. Lynch III (Editor) Written by internationally recognized experts, Pulmonary Hypertension bridges the gap between pulmonology and cardiology to provide clinicians in both disciplines with knowledge of the signs, symptoms, diagnosis, and pharmacologic and surgical treatments for pulmonary hypertension (PH). Through the use of clinical trials, this ground-breaking text supplies a comprehensive review of both the primary and secondary clinical and investigative aspects of this condition. Discussing controversies and concepts in PH diagnosis and management, this guide explores:
|
 |
Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease, Second Edition (Lung Biology in Health and Disease) by T. Douglas Bradley (Editor), John Floras (Editor) Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease specifically addresses the cardiovascular and cerebrovascular consequences of sleep apnea and is geared toward a broad readership of physicians that will ultimately aid patients suffering from sleep apnea. Key features: STAY UP-TO-DATE-new information on medical research and clinical developments makes this resource a must-read for both clinicians and researchers working in the field OPTIMIZE YOUR DIAGNOSTIC SKILLS-with the latest data on the link between cardiovascular and cerebrovascular consequences of sleep apnea, including clinical trials data IMPROVE TREATMENT AND PATIENT OUTCOMES-with broad coverage of sleep apnea and associated conditions, such as hypertension,... |
|
Interstitial Lung Disease by Marvin I. Schwartz (Author), Talmadge E. King (Author) Aims to provide thorough coverage of the clinical and pathogenic aspects of interstitial lung disease. This edition includes new chapters on imaging techniques, bronchoalveolar lavage, immunology of sarcoidosis and inflammation in interstitial lung disease. | |
 |
High-Resolution CT of the Lung by W. Richard Webb (Author), Nestor L Müller (Author), David P Naidich (Author) The thoroughly revised Fourth Edition of this widely acclaimed volume explains how to use the newest high-resolution CT technology to detect and diagnose lung abnormalities. Still the only complete text on the topic, this compact, affordable reference is written by the foremost experts and provides cutting-edge technical and clinical information. It includes state-of-the-art HRCT scans of interstitial lung diseases and differential diagnosis tables summarizing the most helpful diagnostic features of interstitial and airspace diseases. This edition includes full-color illustrations of histologic findings in lung disease, correlated with HRCT manifestations. Also included are updated HRCT images obtained on multidetector CT scanners with many coronal and sagittal reformations. Two new... |
 |
Reichman and Hershfield's Tuberculosis: A Comprehensive, International Approach, Third Edition (Two-Volume Set) (Lung Biology in Health and Disease) by Mario C. Raviglione (Editor) Thoroughly examining tuberculosis from historical, theoretical, and clinical perspectives, this Third Edition merges state-of-the-art research developments with principles of programmatic TB management. Each of the 50 chapters analyze current studies on TB mechanisms and treatment and will meet the needs of all who work in the field of TB control, whether in low-income, high-prevalence areas or in low-prevalence industrialized countries. |
 |
Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease: Volume 13 in the Major Problems in Pathology Series by Anna-Luise A. Katzenstein MD (Editor) Here's a practical, concise manual for diagnosing biopsy specimens. It clarifies accepted diagnostic criteria for non-neoplastic lung diseases; establishes new criteria where needed; and emphasizes the important features in differential diagnosis. A generous bibliography is provided so that you can obtain more in-depth details if desired. The result is enough clearly presented information to enable you to diagnose the majority of non-neoplastic lung diseases without the need for an "expert" opinion. |
|
Sarcoidosis Vasculitis and Diffuse Lung Diseases by Mattioli 1885 Spa |
| © 2009 BrightSurf.com |